NxStage Announces Fourth Quarter 2010 Investor Conference Schedule

Tuesday November 9, 2010

LAWRENCE, Mass., Nov. 9, 2010 /PRNewswire via COMTEX/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer, will participate in the following schedule of investor conferences.

Jefferies 2010 Boston Healthcare Summit

Boston Harbor Hotel

Boston, MA

Tuesday, November 16, 2010

Lazard Capital Markets 7th Annual Healthcare Conference

St. Regis Hotel

New York, NY

Tuesday, November 16, 2010

10:25 a.m. ET

A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of the presentation.

UBS Panel Presentation at ASN

Sheraton Hotel (Downtown)

Denver, CO

Thursday, November 18, 2010

10:00 a.m. MST

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at http://www.nxstage.com/.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Brown’s plans to present at these conferences. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage’s expectations or beliefs as of any date subsequent to the date of this press release.


Kristen K. Sheppard, Esq.

Investor Relations


SOURCE NxStage Medical, Inc.